Doctors could predict whether a man’s prostate cancer will be aggressive at the point of diagnosis – giving him the best ...

People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of ...

A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ...

A new multimillion-pound research programme, involving scientists from The Institute of Cancer Research, London, is aiming to ...

Professor Clare Isacke aims to identify the processes by which tumour cells recruit non-cancerous cells during metastasis. She has held several senior positions at the ICR, including acting as Interim ...

Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, ...

The Institute of Cancer Research, London, has been driving scientific discoveries on cancer and its treatment for more than 100 years. We are internationally renowned for our work into cancer genetics ...

Professor Richard Houlston is Head of the Division of Genetics and Epidemiology. His research focuses on the identification and characterisation of genetic susceptibility to cancer. Group: Myeloma ...

Professor Axel Behrens' group uses a combination of sophisticated genetics and human cancer organoids to understand the biology of cancer and to develop novel therapeutic options, with an emphasis on ...

Dr Rachael Natrajan is researching the ways in which different subgroups of breast cancer can be characterised through genetic analysis of the tumour. By improving this understanding, it is hoped that ...

Dr George’s group is focused on understanding the underlying biology of difficult to treat neuroblastoma and identifying new treatments to target the underlying drivers of aggressive disease. Dr Sally ...

This course is organised by the Joint Department of Physics of T he Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London. The course has been running at the current venue ...